Tech Company Financing Transactions
MitoSense Funding Round
MitoSense closed a $3.5 million Seed funding round on 1/22/2024. Investors included Caydan Capital Partners and private investors.
Transaction Overview
Company Name
Announced On
1/22/2024
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Investors
Caydan Capital Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its innovative work in Mitochondria Organelle Transplantation (MOT).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
330 Chesapeake Drive
Great Falls, VA 22066
USA
Great Falls, VA 22066
USA
Phone
Undisclosed
Website
Email Address
Overview
MitoSense, Inc. is a research and development company in the field of securing development of treatments for neurodegenerative diseases. With exclusively licensed technology to replenish the mitochondria in humans using Mitochondria Organelle Transplantation (MOT�?), the company, through its U.S. based research partner is initially focusing its efforts on treating ALS.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Van Hipp
Chief Executive Officer
Brent Segal
Chief Medical Officer
Catherine Baucom
Chief Scientific Officer
Xian Jiang
Browse more venture capital transactions:
Prev: 1/22/2024: Captain Fresh venture capital transaction
Next: 1/22/2024: Bloom Nutrition venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs